These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 22723882)

  • 1. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease.
    van Koppen A; Joles JA; van Balkom BW; Lim SK; de Kleijn D; Giles RH; Verhaar MC
    PLoS One; 2012; 7(6):e38746. PubMed ID: 22723882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease.
    van Koppen A; Joles JA; Bongartz LG; van den Brandt J; Reichardt HM; Goldschmeding R; Nguyen TQ; Verhaar MC
    Cell Transplant; 2012; 21(10):2299-312. PubMed ID: 23231961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5/6th nephrectomy in combination with high salt diet and nitric oxide synthase inhibition to induce chronic kidney disease in the Lewis rat.
    van Koppen A; Verhaar MC; Bongartz LG; Joles JA
    J Vis Exp; 2013 Jul; (77):e50398. PubMed ID: 23851420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential.
    Klinkhammer BM; Kramann R; Mallau M; Makowska A; van Roeyen CR; Rong S; Buecher EB; Boor P; Kovacova K; Zok S; Denecke B; Stuettgen E; Otten S; Floege J; Kunter U
    PLoS One; 2014; 9(3):e92115. PubMed ID: 24667162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Marrow-Derived Mesenchymal Stem Cells and Their Conditioned Medium Attenuate Fibrosis in an Irreversible Model of Unilateral Ureteral Obstruction.
    da Silva AF; Silva K; Reis LA; Teixeira VP; Schor N
    Cell Transplant; 2015; 24(12):2657-66. PubMed ID: 25695732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation.
    Chang JW; Tsai HL; Chen CW; Yang HW; Yang AH; Yang LY; Wang PS; Ng YY; Lin TL; Lee OK
    J Cell Mol Med; 2012 Dec; 16(12):2935-49. PubMed ID: 22862802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.
    Rota C; Morigi M; Cerullo D; Introna M; Colpani O; Corna D; Capelli C; Rabelink TJ; Leuning DG; Rottoli D; Benigni A; Zoja C; Remuzzi G
    Stem Cell Res Ther; 2018 Aug; 9(1):220. PubMed ID: 30107860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progenitor cell secretory products exert additive renoprotective effects when combined with ace inhibitors in experimental CKD.
    Kepecs DM; Yuen DA; Zhang Y; Thai K; Connelly KA; Gilbert RE
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27638853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction.
    Liu B; Ding FX; Liu Y; Xiong G; Lin T; He DW; Zhang YY; Zhang DY; Wei GH
    Nephrology (Carlton); 2018 Aug; 23(8):728-736. PubMed ID: 28667820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous administration of iPS-MSC
    Sheu JJ; Sung PH; Wallace CG; Yang CC; Chen KH; Shao PL; Chu YC; Huang CR; Chen YL; Ko SF; Lee MS; Yip HK
    J Cell Mol Med; 2020 Mar; 24(6):3593-3610. PubMed ID: 32061051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose-Derived Mesenchymal Stem Cells and Conditioned Medium Attenuate the Memory Retrieval Impairment During Sepsis in Rats.
    Akhondzadeh F; Kadkhodaee M; Seifi B; Ashabi G; Kianian F; Abdolmohammadi K; Izad M; Adelipour M; Ranjbaran M
    Mol Neurobiol; 2020 Sep; 57(9):3633-3645. PubMed ID: 32562236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Healing Effects of Conditioned Medium Derived from Mesenchymal Stem Cells on Radiation-Induced Skin Wounds in Rats.
    Sun J; Zhang Y; Song X; Zhu J; Zhu Q
    Cell Transplant; 2019 Jan; 28(1):105-115. PubMed ID: 30350716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient nitric oxide reduction induces permanent cardiac systolic dysfunction and worsens kidney damage in rats with chronic kidney disease.
    Bongartz LG; Braam B; Verhaar MC; Cramer MJ; Goldschmeding R; Gaillard CA; Doevendans PA; Joles JA
    Am J Physiol Regul Integr Comp Physiol; 2010 Mar; 298(3):R815-23. PubMed ID: 20032261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes.
    Nagaishi K; Mizue Y; Chikenji T; Otani M; Nakano M; Konari N; Fujimiya M
    Sci Rep; 2016 Oct; 6():34842. PubMed ID: 27721418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects.
    Osugi M; Katagiri W; Yoshimi R; Inukai T; Hibi H; Ueda M
    Tissue Eng Part A; 2012 Jul; 18(13-14):1479-89. PubMed ID: 22443121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urotensin II in the development and progression of chronic kidney disease following ⅚ nephrectomy in the rat.
    Eyre HJ; Speight T; Glazier JD; Smith DM; Ashton N
    Exp Physiol; 2019 Mar; 104(3):421-433. PubMed ID: 30575177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progenitor-like cells derived from mouse kidney protect against renal fibrosis in a remnant kidney model via decreased endothelial mesenchymal transition.
    Chen CL; Chou KJ; Fang HC; Hsu CY; Huang WC; Huang CW; Huang CK; Chen HY; Lee PT
    Stem Cell Res Ther; 2015 Dec; 6():239. PubMed ID: 26631265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes from conditioned media of bone marrow-derived mesenchymal stem cells promote bone regeneration by enhancing angiogenesis.
    Takeuchi R; Katagiri W; Endo S; Kobayashi T
    PLoS One; 2019; 14(11):e0225472. PubMed ID: 31751396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects and mechanism of conditioned media from human mesenchymal stem cells on anti-GBM glomerulonephritis in WKY rats.
    Iseri K; Iyoda M; Ohtaki H; Matsumoto K; Wada Y; Suzuki T; Yamamoto Y; Saito T; Hihara K; Tachibana S; Honda K; Shibata T
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1182-91. PubMed ID: 27053690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats.
    Reis LA; Borges FT; Simões MJ; Borges AA; Sinigaglia-Coimbra R; Schor N
    PLoS One; 2012; 7(9):e44092. PubMed ID: 22970165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.